MedCan Summit Speaker

Mitch Cuevas
Mitch is an experienced CEO & Executive Director with a demonstrated history of working in and delivering value to FMCG, pharmaceutical & manufacturing industries, most specifically in food, pharmaceuticals, personal care / health care sectors.
He was the Managing Director of API Consumer Brands, an Auckland based high-end manufacturer and distributer of pharmaceuticals, wellness products and consumer toiletries. API (NZ) has a turnover over $70M+, 250+ staff, with markets in NZ, Australia and Asia. With its two manufacturing plants, it’s the largest manufacturer of controlled substances (medicines) in the Southern Hemisphere and the largest supplier of analgesics (pain medications) to the NZ market. It supplies to Pharmac (NZ), pharmacy and retail in NZ, Australia and across Asia.
Mitch’s commercial career has been centred on consumer goods, financial performance management and manufacturing for 25+ years. He has been actively involved in a number of M&A activities, export expansions and successful business “commercial rescues”.
In NZ, Mitch has also held senior management/CEO positions at some of NZ’s most respected companies – Fonterra, Air NZ, Goodman Fielder and Ecostore.
Prior to arriving in New Zealand in 2002 he had lived in the UK, Brazil, Spain and the USA and had worked for (or consulted to) several global companies including: Unilever, Cadbury Schweppes, Ericsson, United Airlines, Heineken, Kelloggs, Nabisco, Telefonica and Ford Motor Group.
He earned his BA in International Business from San Diego State University in ‘92, an MBA from London Business School in ‘97, and General Management from Harvard Business School in ’04.
Mitch is a Director at the CEO Institute, a member of Young Presidents Association (YPO Global) and NZ Institute of Directors(IOD) and a past lecturer on Leadership. He is also fluent in both Spanish and Portuguese.
All Sessions by Mitch Cuevas
Day 1 - Industry Summit - 10 February |
Time | Industry Stream | Science Stream |
---|---|---|
10:05 | CEO panel: The state of play for New Zealand’s medicinal cannabis industry in 2022 and beyond ![]() ![]()
Manu Caddie, Co-Founder, Kaihautu – Innovation and Regulation, Rua Bioscience Carmen Doran Chief Executive Officer, Helius Therapeutics Mark Lucas Chief Executive Officer, Cannasouth Tim Aldridge Managing Director, Puro Mitch Cuevas Pharmaceutical Director, Eqalis | CEO panel: The state of play for New Zealand’s medicinal cannabis industry in 2022 and beyond ![]() ![]()
Manu Caddie, Co-Founder, Kaihautu – Innovation and Regulation, Rua Bioscience Carmen Doran Chief Executive Officer, Helius Therapeutics Mark Lucas Chief Executive Officer, Cannasouth Tim Aldridge Managing Director, Puro Mitch Cuevas Pharmaceutical Director, Eqalis |
Day 2 - Industry Summit - 11 February |
Time | Plenary |
---|---|
11:00 | New Zealand’s 2 Billion Dollar Opportunity ![]() ![]()
Mitch Cuevas Pharmaceutical Director, Eqalis |
More Speakers
Clinical Director
GM - Forests to Biobased products
Cannabis Consultant, Addiction Specialist, General Practitioner